Sort   by:  
 Page size 
UnknownA novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signaling.
Not available
S-EPMC10716160 | biostudies-literature
UnknownXELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Not available
S-EPMC10987514 | biostudies-literature
Sort   by:  
 Page size